Health Invest Partners Ab Biogen Inc. Transaction History

Health Invest Partners Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	SELL	$187.54 - $223.02 $2.25 Million - $2.68 Million	-12,000 Reduced 42.86%	16,000 $3.26 Million
Q1 2022 May 05, 2022	BUY	$193.77 - $244.14 $5.43 Million - $6.84 Million	28,000 New	28,000 $5.9 Million
Q4 2020 Feb 05, 2021	SELL	$236.26 - $355.63 $1.98 Million - $2.99 Million	-8,400 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$307.64 - $344.58 $3.69 Million - $4.13 Million	-12,000 Reduced 58.82%	8,400 $2.68 Million
Q3 2017 Nov 13, 2017	SELL	$281.15 - $329.69 $1.29 Million - $1.52 Million	-4,600 Reduced 18.4%	20,400 $6.39 Million
Q2 2017 Aug 07, 2017	BUY	N/A	25,000	25,000 $6.78 Million

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

Stay updated on Health Invest Partners Ab with notifications on news.